Clinical Trials in Baltimore

Showing 7521-7540 of 17,842 trials

Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes

NCT00361296

RATIONALE: Vaccines made from cancer cells may help the body build an effective immune response to kill abnormal cells. PURPOSE: This clinical trial is studying how well vaccine therapy works in treating patients with myelodysplastic syndromes (MDS).

Myelodysplastic Syndromes

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins9 participantsStarted Sep 2007

Baltimore, Maryland, United States

TERMINATEDNA< 1 mile

OPTIMIZE IDE for the Treatment of ACS

NCT03190473

Indication for use: "The Svelte DES is indicated for improving coronary luminal diameter in patients with symptomatic heart disease, including patients with non-ST elevation MI due to discrete de novo native coronary artery lesions. The treated lesion length should be less than the nominal stent length with a reference vessel diameter of 2.25 mm - 4.00 mm

Acute Coronary Syndrome

Svelte Medical Systems, Inc.1,630 participantsStarted Jan 2018

Fairhope, Alabama, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +69 more locations

Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes

OPTIMIZE IDE for the Treatment of ACS

Find Trials by Condition in Baltimore

Brain Imaging of Cannabinoid Receptors

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

The Effects of Chronic Exposure to Low-Level Blasts

3D Prediction of Patient-Specific Response

A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Assessment of Acute Disease to Reduce Imaging Costs

Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer

The TREFOIL Concept 5 Year Clinical Investigation